Treatment of anorexia nervosa with palmitoylethanoamide

Med Hypotheses. 2018 Jul:116:54-60. doi: 10.1016/j.mehy.2018.04.010. Epub 2018 Apr 12.

Author

Barbara Scolnick¹

Affiliation

¹ Boston University, Dept of Psychological and Brain Sciences, 64 Cummington Street, Boston, MA 02215, United States. Electronic address: scolnick@bu.edu.

PMID: 29857912
DOI: 10.1016/j.mehy.2018.04.010

No abstract available

MeSH terms

Amides
Animals
Anorexia Nervosa / drug therapy*
Arachidonic Acids / metabolism
Dietary Fats
Dietary Supplements*
Endocannabinoids / chemistry
Endocannabinoids / metabolism
Ethanolamines / therapeutic use*
Feeding Behavior
Humans
Lipids / blood
Lipids / chemistry
Oleic Acids / chemistry
Palmitic Acids / therapeutic use*
Polyunsaturated Alkamides / metabolism
Rats
Receptor, Cannabinoid, CB1 / metabolism
Receptor, Cannabinoid, CB2 / metabolism

Substances

Amides
Arachidonic Acids
Dietary Fats
Endocannabinoids
Ethanolamines
Lipids
Oleic Acids
Palmitic Acids
Polyunsaturated Alkamides
Receptor, Cannabinoid, CB1
Receptor, Cannabinoid, CB2
oleoylethanolamide
palmidrol
anandamide